Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) Antibody

Este producto es parte de KIR3DL - Killer cell immunoglobulin-like receptor 3DL
Product Graph
312€ (60 µl)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx136027
tested applications
WB

Description

KIR3DL2 Antibody is a Rabbit Polyclonal against KIR3DL2.

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
Target: Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2)
Immunogen: Recombinant fusion protein corresponding to human KIR3DL2
Host
Rabbit
Reactivity
Human, Mouse, Rat
Assay Type
Concentration: 1 mg/ml
Recommended Dilution
WB: 1/500 - 1/2000. Optimal dilutions/concentrations should be determined by the end user.
Clonality
Polyclonal
Conjugation
Unconjugated
Isotype
IgG
Observed MW
Calculated MW: 48 kDa/50 kDa  Observed MW: 50 kDa
Purification
Purified by affinity chromatography.
Size 1
60 µl
Size 2
120 µl
Size 3
200 µl
Form
Liquid
Tested Applications
WB
Buffer
PBS, pH 7.3, containing 0.02% sodium azide, 50% glycerol.
Availability
Shipped within 5-7 working days.
Storage
Aliquot and store at -20°C. Avoid repeated freeze/thaw cycles.
Dry Ice
No
UniProt ID
P43630
Gene ID
3812
NCBI Accession
NP_006728.2
Alias
CD158 antigen-like family member K,Natural killer-associated transcript 4,NKAT-4,p70 natural killer cell receptor clone CL-5,3DL2,CD158K,NKAT4B,KIR-3DL2
Background
Antibody anti-KIR3DL2
Status
RUO
Note
THIS PRODUCT IS FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC, THERAPEUTIC OR COSMETIC PROCEDURES. NOT FOR HUMAN OR ANIMAL CONSUMPTION.

Descripción

Killer Cell Immunoglobulin-Like Receptor 3DL2 (KIR3DL2) is a member of the KIR family of receptors expressed predominantly on natural killer (NK) cells and subsets of T cells, playing a significant role in immune system regulation and surveillance. This receptor specifically interacts with HLA class I molecules, with a preference for HLA-A3 and HLA-A11 alleles, delivering inhibitory signals that modulate NK cell cytotoxicity and cytokine production. KIR3DL2 polymorphisms and expression levels have been implicated in susceptibility to autoimmune diseases such as ankylosing spondylitis and certain infections, demonstrating its critical role in balancing immune activation and tolerance. Recent studies highlight the involvement of KIR3DL2 in cancer, particularly in Hodgkin’s lymphoma, where it may serve as a therapeutic target for novel immunotherapies. Through its inhibitory signaling and interaction with diverse HLA ligands, KIR3DL2 ensures immune homeostasis while also influencing outcomes in transplantation and disease progression.

Related Products

abx067653

Human Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) Protein

Human Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) is a recombinant Human protein expressed in E. coli.

Ver Producto
abx104484

Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) Antibody

Polyclonal Antibody to Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2).

Ver Producto
abx136027

Killer Cell Immunoglobulin Like Receptor 3DL2 (KIR3DL2) Antibody

KIR3DL2 Antibody is a Rabbit Polyclonal against KIR3DL2.

Ver Producto